Summary
- Current Price
- As of today, ELV price is $420.07, down -0.46% on
- Current Price All-Time High
- ELV price is currently -25.95% below its historical high of $567.26 set on
- Market Cap
- ELV current market cap is $91B, up +29.35% over the past 365 days
- PE Ratio
- ELV current PE ratio is 17.91
- Revenue
- ELV current annual revenue is $199.13B, up +12.62% year-over-year
- Next Earnings
- The next earnings release for ELV is on
Profile
| Metric | Value |
|---|---|
| Full Name | Elevance Health, Inc. |
| Ticker | NYSE: ELV |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Healthcare Plans |
| Country | United States |
| IPO | |
| Indexes | |
| Website | elevancehealth.com |
| Employees | 104,200 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $420.07 | |
| Price, 1D Change | -0.46% | |
| Market Cap | $91B | |
| TTM Dividend Yield | 1.64% | |
| PE Ratio | 17.91 | |
| Beta | 0.29 | |
| Revenue | $199.13B | |
| Revenue, 1Y Change | +12.62% | |
| EPS | $25.21 | |
| EPS, 1Y Change | -1.82% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $1.72 | |
| Next Ex-Dividend | $1.72 | |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | ANTM | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | $25.21 | |
| EPS Estimate | $29.14 | |
| EPS Est. Change | +15.59% | |
| Revenue | $199.13B | |
| Revenue Estimate | $198.85B | |
| Revenue Est. Change | -0.14% | |
| Current Price | $420.07 | |
| Price Target | $492.00 | - |
| Price Tgt. Change | +17.12% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $32.97 | $25.68 | -22.11% | |
| $29.97 | $25.21 | -15.89% | |
| $29.14 | N/A | +15.59% | |
| $30.30 | N/A | +20.19% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $174.96B | $176.81B | +1.06% | |
| $197.74B | $199.13B | +0.70% | |
| $198.85B | N/A | -0.14% | |
| $203.75B | N/A | +2.32% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | +32.43% | |
| Price, 3Y | -6.96% | |
| Market Cap, 1Y | +29.35% | |
| Market Cap, 3Y | -14.11% | |
| Revenue, 1Y | +12.62% | |
| Revenue, 3Y | +27.16% | |
| EPS, 1Y | -1.82% | |
| EPS, 3Y | +3.85% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $420.07 | |
| SMA 200 | $372.35 | |
| SMA 50 | $410.56 | |
| EMA 200 | $385.29 | |
| EMA 50 | $412.26 | |
| MACD | $5.12 | |
| Beta | 0.29 | |
| ATR | $11.55 | |
| 14-Day RSI | 50.77 | |
| 10-Day Volatility | 29.28% |
Dividends
| Metric | Value | Date |
|---|---|---|
| Last Paid | $1.72 | |
| Upcoming | $1.72 | |
| Dividend Yield | 1.63% | |
| Total Dividend | $6.84 | |
| $1.53B | ||
| 27.01% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $199.13B | |
| EPS | $25.21 | |
| Gross Profit | $0.00 | |
| Gross Margin | 0.00% | |
| Operating Income | $8.11B | |
| Operating Margin | 4.07% | |
| Net Income | $5.66B | |
| Net Margin | 2.84% | |
| EBITDA | $8.26B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.73 | |
| 1.54 | ||
| - | ||
| - | ||
| 6 | ||
| 3.15 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | 17.91 | |
| 0.45 | ||
| 2.04 | ||
| 14.41 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $43.88B | |
| $9.49B | ||
| $121.49B | ||
| $63.00B | ||
| $77.47B | ||
| $41.04B | ||
| Total Debt | $32.05B | |
| $1.38B | ||
| $7.32B |
Expenses
| Metric | Value | Date |
|---|---|---|
| $193.46B | ||
| -$8.11B | ||
| - | ||
| $0.00 | ||
| $1.55B | ||
| $0.00 | ||
| $1.05B |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $4.29B | ||
| -$1.34B | ||
| -$1.74B | ||
| Capex | $1.12B | |
| $3.17B |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Wells Fargo | → | |
| TD Cowen | → | |
| UBS | → | |
| RBC Capital | → | |
| Morgan Stanley | → | |
| Guggenheim | → | |
| Barclays | → | |
| Baird | → | |
| Guggenheim | → | |
| Barclays | → |
Analyst sentiment
Institutional ownership
Screeners with ELV
FAQ
- What is the ticker symbol for Elevance Health, Inc.?
- The ticker symbol for Elevance Health, Inc. is NYSE:ELV
- Does Elevance Health, Inc. pay dividends?
- Yes, Elevance Health, Inc. pays dividends. The last payment was $1.72, with an ex-dividend date on September 10, 2026
- What sector is Elevance Health, Inc. in?
- Elevance Health, Inc. is in the Healthcare sector
- What industry is Elevance Health, Inc. in?
- Elevance Health, Inc. is in the Healthcare Plans industry
- What country is Elevance Health, Inc. based in?
- Elevance Health, Inc. is headquartered in United States
- When did Elevance Health, Inc. go public?
- Elevance Health, Inc. initial public offering (IPO) was on October 30, 2001
- Is Elevance Health, Inc. in the S&P 500?
- Yes, Elevance Health, Inc. is included in the S&P 500 index
- Is Elevance Health, Inc. in the NASDAQ 100?
- No, Elevance Health, Inc. is not included in the NASDAQ 100 index
- Is Elevance Health, Inc. in the Dow Jones?
- No, Elevance Health, Inc. is not included in the Dow Jones index
- When was Elevance Health, Inc. last earnings report?
- Elevance Health, Inc.'s most recent earnings report was on October 21, 2026
- When does Elevance Health, Inc. report earnings?
- The next expected earnings date for Elevance Health, Inc. is January 28, 2027
Data Sources & References
- ELV Official Website www.elevancehealth.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1156039/000115603926000006/0001156039-26-000006-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- ELV Profile on Yahoo Finance finance.yahoo.com/quote/ELV
- ELV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/elv